Search Results - U Germing

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    P589: AGE AND AGE-ADAPTED RISK FACTORS HIGHLY INFLUENCE SURVIVAL PROBABILITY IN AML PATIENTS – A RETROSPECTIVE ANALYSIS by K. Nachtkamp, C. Zahner, A. Fricke, T. Ulrych, F. I. Schulz, A. Kündgen, P. S. Jäger, G. Kobbe, U. Germing

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P772: PROGNOSTIC IMPACT OF DISEASE-RELATED RISK FACTORS AND TREATMENT APPROACHES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES (MDS) by C. Lesch, A. Kündgen, K. Nachtkamp, A. Kasprzak, C. Strupp, M. Rudelius, N. Gattermann, G. Kobbe, B. Hildebrandt, U. Germing

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    LUSPATERCEPT UTILIZATION PATTERNS IN LOWER-RISK MYELODYSPLASTIC SYNDROMES: FINDINGS FROM A MULTINATIONAL MEDICAL RECORD REVIEW STUDY by M Díez-Campelo, A Yucel, RK Goyal, MB Glassberg, EM Cavalcante, E Esterberg, J Rombi, KL Davis, D Miteva, U Germing

    Published in Hematology, Transfusion and Cell Therapy (2024-10-01)
    Get full text
    Article


  4. 4

    P783: SYSTEMIC THERAPY UTILIZATION AND HEMATOLOGIC OUTCOMES IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS): FINDINGS FROM A REAL-WORLD MEDICAL RECORD REVIEW STUDY IN THE US, UK,... by M. Diez-Campelo, A. Yucel, R. Goyal, R. C. Parikh, S. Dhuliawala, M. Jimenez, M. Sluga-O’Callaghan, C. Hughes, D. Tang, U. Germing

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY by F. Schulz, J. Kostova, B. Hildebrandt, K. Nachtkamp, C. Strupp, N. Gattermann, M. Lübbert, S. Blum, S. Parmentier, K. Götze, J. Lipke, F. Beier, W.-K. Hofmann, U. Germing

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P532: ACUTE MYELOID LEUKEMIA (AML): UNICENTRIC REPORT ON 1029 PATIENTS DIAGNOSED IN TERTIAL REFERAL CENTER by A. Fricke, K. Nachtkamp, K. Döhner, B. Hildebrandt, B. Betz, M. Rudelius, M. Seidl, C. Zahner, G. Kobbe, A. Kündgen, P. S. Jäger, B.-N. Baermann, U. Germing

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    C052 | OUTCOMES OF IMETELSTAT THERAPY IN PATIENTS WITH RING SIDEROBLAST–NEGATIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES FROM THE POOLED IMERGE STUDY POPULATIONS by V. Santini, U. Platzbecker, A.M. Zeidan, M.A. Sekeres, A. Raza, M. Mittelman, S. Thépot, R. Buckstein, U. Germing, Y. F. Madanat, M. Díez-Campelo, D. Valcárcel, A. Jonášová, S. Dougherty, Q. Xia, L. Sun, S. Navada, F. Feller, M.R. Savona, R.S. Komrokji, P. Fenaux

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  8. 8

    S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS. by H. Garelius, A. Smith, T. Bagguley, A. Taylor, P. Fenaux, D. Bowen, A. Symeonidis, M. Mittelmann, R. Stauder, J. Čermák, G. Sanz, S. Langemeijer, L. Malcovati, U. Germing, R. Itzykson, A. Guerci-Bresler, D. Culligan, I. Kotsianidis, K. Koinig Mag, C. van Marrewijk, S. Crouch, T. de Witte, E. Hellström-Lindberg

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    P448: PROGNOSTIC IMPACT OF SOMATIC CEBPA BZIP DOMAIN MUTATIONS IN ACUTE MYELOID LEUKEMIA by F. G. Ruecker, A. Corbacioglu, F. Theis, M. Christopeit, U. Germing, G. Wulf, M. Abu Samra, L. Teichmann, M. Lübbert, M. W. Kühn, M. Bentz, J. Westermann, L. Bullinger, V. I. Gaidzik, E. Jahn, M. Gröger, S. Kapp-Schwoerer, D. Weber, F. Thol, M. Heuser, A. Ganser, H. Döhner, K. Döhner

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  10. 10

    C053 | REAL-WORLD, MULTI-OMICS VALIDATION OF THE CLINICAL RELEVANCE OF MOLECULAR TAXONOMY FOR MYELODYSPLASTIC SYNDROMES. AN INTERNATIONAL STUDY ON BEHALF OF GENOMED4ALL, SYNTHEMA A... by G. Maggioni, G. Todisco, E. Sauta, L. Lanino, S. Ball, Jp Bewersdorf, T Kewan, Nh Al Ali, P. Fenaux, U Platzbecker, V. Santini, Z Xie, AM. Brunner, At Kuykendall, JM. Bennett, R. Buckstein, R. Bejar, He Carraway, Ae Dezern, Ea Griffiths, S. Halene, Rp Hasserjian, Af List, S. Loghavi, O Odenike, E. Padron, MM. Patnaik, Gj Roboz, Maximilian Stahl, Ma Sekeres, Dp Steensma, Mr Savona, J Taylor, Ml Xu, Da Sallman, Sd Nimer, Cs Hourigan, Ah Wei, A. Campagna, M. Ubezio, E. Riva, D. Ventura, N. Pinocchio, M. Zampini, A. Buizza, A. Russo, F. Pesce, G. Asti, M. Delleani, E. Travaglino, Ca Tentori, I. Ferrari, A. Crespi, G. Figini, M. Di Matteo, M. Brindisi, L. Crisafulli, F. Ficara, G. Castellani, UM. Borate, F. Efficace, Sd Gore, Tk Kim, Aa Van De Loosdrecht, N. Daver, M. Rozman, A. Orfao, Sa Wang, K Foucar, M. Iastrebner, P. Scheinberg, Y Miyazaki, M. Mittelmann, T Cluzeau, L. Ades, U Germing, S. Kordasti, T Haferlach, AM. Zeidan, Rs Komrokji, Mg Della Porta.

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: